Equillium, Inc. (EQ) Discusses Aryl Hydrocarbon Receptor as a Drug Target and EQ504 Program in Immune-Mediated Diseases – Slideshow
Source: https://seekingalpha.com/article/4841100-equillium-inc-eq-discusses-aryl-hydrocarbon-receptor-as-a-drug-target-and-eq504-program-in?source=feed_all_articles